Do I need a prescription to take cyproterone?

Cyproterone acetate is a prescription-only medicine everywhere it is licensed. It is not an over-the-counter product and should not be taken without the supervision of a healthcare professional. But that answer opens the door to many other questions: why is a prescription necessary? What are the risks of taking it without medical supervision? And what does the research actually show about how well it works? This article summarises what regulators and the published literature say.

Not Just Any Drug

Cyproterone acetate (sometimes simply called cyproterone) is a synthetic hormonal medication that acts primarily as an antiandrogen. This means it blocks the effects of androgens, a type of sex hormone such as testosterone. It is used in some countries for conditions like severe acne, hirsutism (excess hair growth), or androgenetic alopecia, and it also appears in treatment protocols for trans women, people with prostate cancer, and cases of hypersexuality.

Because of the powerful way it acts on the hormonal system, taking it without a prescription carries real health risk. Altering the body's hormone levels can have deep and lasting consequences, which is why it is a controlled prescription medicine in the countries that license it. It is not approved by the FDA for any indication in the United States, while it is used in Europe and Latin America under medical supervision.

What If I Take It Without a Prescription?

Taking cyproterone without a prescription means starting a hormonal treatment without knowing your hormonal profile, without knowing whether you actually have excess androgens, and without the blood monitoring that prescribers use to catch problems early. Cyproterone acetate product information lists serious adverse effects, including fatigue, depression and liver injury. In 2020, the European Medicines Agency (EMA) restricted cyproterone-containing medicines because of a dose-related risk of meningioma — a usually benign brain tumour — reported mainly in people taking 25 mg a day or more for several years, and it advised that treatment be stopped permanently in anyone diagnosed with one (EMA, 2020). Those are the reasons regulators made it prescription-only: the monitoring is part of the treatment, not an optional extra.

What Does the Research Show?

Antiandrogens including cyproterone are used for androgen-driven conditions, but the evidence base is weaker than the marketing around these treatments suggests. A 2015 Cochrane systematic review of interventions for hirsutism found that most of the relevant trials were small and of low methodological quality, and that firm conclusions about individual antiandrogen and oral-contraceptive regimens could not be drawn (van Zuuren et al., 2015).

For hair loss specifically, the clearest trial evidence is Vexiau and colleagues (2002), who randomised 66 women with androgenetic alopecia to topical minoxidil 2% or to cyproterone acetate with ethinylestradiol over twelve months. In that trial minoxidil performed better overall on hair density, particularly in women without hyperandrogenism, while cyproterone did comparatively better in the subgroup with raised androgens or menstrual disturbance. It is a single small trial, and it does not establish cyproterone as a proven treatment for hair loss.

Reported side effects in this setting include breast tenderness, mood changes and fluid retention, and prescribers monitor liver function during treatment. This is part of why a prescription is required: a medicine with real effects is not a harmless one.

Why Isn't It Approved in the United States?

Although cyproterone acetate is widely used in Europe and Latin America, it has not been approved by the FDA. That does not by itself mean it is a bad drug — it means no approved US application exists, and other options are already licensed there. The FDA has not published a rationale for the absence of an approval, so any explanation offered for it is inference rather than a regulator's stated position. Other medicines such as spironolactone or finasteride are more commonly used in the US for androgen-related conditions in women; finasteride is not approved for female hair loss either and carries its own pregnancy contraindication.

USER EXPERIENCES

Beyond scientific studies and regulatory decisions, it is also worth knowing how people describe cyproterone in practice. On the Tressless community forum, where thousands of users share their journeys with hair loss treatments, cyproterone often appears in discussions among women and transfeminine individuals exploring ways to reduce androgen-related hair issues. These are personal accounts, not measured outcomes.

Some users have reported positive outcomes. One transfeminine user shared that after months on cyproterone under medical supervision, they experienced a noticeable reduction in scalp oiliness and hair shedding. They emphasised that the improvement was slow and only became apparent after several months. Another user described emotional stabilisation alongside physical changes, especially when cyproterone was combined with estradiol.

However, many users also express serious concerns. Some report episodes of extreme fatigue, mood swings, and loss of libido. One user described feeling "completely emotionally flat," while others noted liver enzyme elevation in routine blood tests. These reports underscore the importance of monitoring and regular medical checkups. A recurring theme is inconsistent access: in some countries cyproterone is prescribed readily, while in others it is unavailable. Some community members say they have obtained it from unregulated overseas sellers — a route with no guarantee of what is in the product, and no monitoring behind it, which is why it is a bad idea rather than a workaround.

One user described ordering cyproterone online without a prescription and experiencing dizziness, nausea, and panic attacks within weeks. Their post drew many comments urging people not to take hormonal medications without medical oversight. Overall, the Tressless community illustrates that experiences with cyproterone vary widely, and many users echo the same message: this is not a drug to experiment with alone.

Talk to a doctor or pharmacist before starting, stopping or combining cyproterone acetate, and do not adjust a prescribed dose yourself. Cyproterone is a teratogen: product information contraindicates it in pregnancy, advises effective contraception for anyone who could become pregnant during treatment, and advises against handling broken or crushed tablets.

References

van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015). Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews, 2015(4), CD010334. https://pubmed.ncbi.nlm.nih.gov/25918921/

Vexiau, P., Chaspoux, C., Boudou, P., Fiet, J., Jouanique, C., Hardy, N., & Reygagne, P. (2002). Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. British Journal of Dermatology, 146(6), 992–999. https://pubmed.ncbi.nlm.nih.gov/12072067/

European Medicines Agency. (2020). Cyproterone medicines: new restrictions due to risk of meningioma. https://www.ema.europa.eu/en/news/cyproterone-medicines-new-restrictions-due-risk-meningioma